A comprehensive view of AmerisourceBergen Corp.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Study finds US drug distribution industry expands as COVID-19 disruption fades and biosimilars boom; combined revenue at AmerisourceBergen, Cardinal Health, McKesson projected to reach US$616.0B in 2022: Drug Channels Institute

AmerisourceBergen acquiring German life sciences services firm PharmaLex Holding for €1.28 billion; deal to enhance AmerisourceBergen’s European presence in pharmaceutical distribution, biopharma manufacturer services capabilities

AmerisourceBergen signs US$19.8M deal with HHS to distribute up to 2,500 shipments per week of Bavarian Nordic’s Jynneos vaccine and Siga’s TYPOXX to treat monkeypox; Jynneos is shipped frozen, TYPOXX is shipped at ambient temperature

Eli Lilly’s COVID-19 drug bebtelovimab commercially available in US from distributor AmerisourceBergen to states, hospitals, healthcare providers; drug authorized for emergency use to treat mild-to-moderate COVID-19 in adults, high-risk kids 12 or older

AmerisourceBergen reports fiscal year 2022 Q3 GAAP net income up at US$407.0M from US$292.1M a year ago, with revenue up 12.5% year-over-year to US$60.1B; growth driven by 120.3% increase in International Healthcare Solutions revenue

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count